[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cancer Treatment Drugs Market Research Report 2012-2024

July 2019 | 136 pages | ID: G99AE74006BEN
HeyReport

US$ 3,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

The global Cancer Treatment Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Roche
  • Novartis
  • Celgene
  • Amgen
  • Johnson & Johnson
  • Bristol-Myers Squibb
  • Takeda
  • Eli Lilly
  • Pfizer
  • AstraZeneca
  • Astellas
  • Sanofi
  • Bayer
  • Merck & Co.
  • Biogen Idec
  • Kyowa Hakko Kirin
  • Otsuka
  • Teva
  • Eisai
  • Merck KGaA
  • Ipsen
  • AbbVie
  • Gilead Sciences
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory/Lung Cancer
  • Other Cancers
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 Chemotherapy
    1.2.1.2 Targeted Therapy
    1.2.1.3 Immunotherapy (Biologic Therapy)
    1.2.1.4 Hormonal Therapy
    1.2.1.5 Others
  1.2.2 by Application
    1.2.2.1 Blood Cancer
    1.2.2.2 Breast Cancer
    1.2.2.3 Gastrointestinal Cancer
    1.2.2.4 Prostate Cancer
    1.2.2.5 Respiratory/Lung Cancer
    1.2.2.6 Other Cancers
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Chemotherapy Market, 2013-2018
  4.1.2 Targeted Therapy Market, 2013-2018
  4.1.3 Immunotherapy (Biologic Therapy) Market, 2013-2018
  4.1.4 Hormonal Therapy Market, 2013-2018
  4.1.5 Others Market, 2013-2018
4.2 Market Forecast
  4.2.1 Chemotherapy Market Forecast, 2019-2024
  4.2.2 Targeted Therapy Market Forecast, 2019-2024
  4.2.3 Immunotherapy (Biologic Therapy) Market Forecast, 2019-2024
  4.2.4 Hormonal Therapy Market Forecast, 2019-2024
  4.2.5 Others Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Blood Cancer Market, 2013-2018
  5.1.2 Breast Cancer Market, 2013-2018
  5.1.3 Gastrointestinal Cancer Market, 2013-2018
  5.1.4 Prostate Cancer Market, 2013-2018
  5.1.5 Respiratory/Lung Cancer Market, 2013-2018
  5.1.6 Other Cancers Market, 2013-2018
5.2 Market Forecast
  5.2.1 Blood Cancer Market Forecast, 2019-2024
  5.2.2 Breast Cancer Market Forecast, 2019-2024
  5.2.3 Gastrointestinal Cancer Market Forecast, 2019-2024
  5.2.4 Prostate Cancer Market Forecast, 2019-2024
  5.2.5 Respiratory/Lung Cancer Market Forecast, 2019-2024
  5.2.6 Other Cancers Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Roche
8.2 Novartis
8.3 Celgene
8.4 Amgen
8.5 Johnson & Johnson
8.6 Bristol-Myers Squibb
8.7 Takeda
8.8 Eli Lilly
8.9 Pfizer
8.10 AstraZeneca
8.11 Astellas
8.12 Sanofi
8.13 Bayer
8.14 Merck & Co.
8.15 Biogen Idec
8.16 Kyowa Hakko Kirin
8.17 Otsuka
8.18 Teva
8.19 Eisai
8.20 Merck KGaA
8.21 Ipsen
8.22 AbbVie
8.23 Gilead Sciences

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Cancer Treatment Drugs
Table Products Segment of Cancer Treatment Drugs
Table Chemotherapy Overview
Table Targeted Therapy Overview
Table Immunotherapy (Biologic Therapy) Overview
Table Hormonal Therapy Overview
Table Others Overview
Table Global Cancer Treatment Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Cancer Treatment Drugs
Table Blood Cancer Overview
Table Breast Cancer Overview
Table Gastrointestinal Cancer Overview
Table Prostate Cancer Overview
Table Respiratory/Lung Cancer Overview
Table Other Cancers Overview
Table Global Cancer Treatment Drugs Market by Application, 2011-2022 (USD Million)
Table Global Cancer Treatment Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Cancer Treatment Drugs
Table Market Dynamics
Table Policy of Cancer Treatment Drugs
Table GDP of Major Countries
Table Chemotherapy CAGR by Revenue and Volume, 2012-2018
Table Targeted Therapy CAGR by Revenue and Volume, 2012-2018
Table Immunotherapy (Biologic Therapy) CAGR by Revenue and Volume, 2012-2018
Table Hormonal Therapy CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Chemotherapy CAGR by Revenue and Volume, 2012-2024
Table Targeted Therapy CAGR by Revenue and Volume, 2012-2024
Table Immunotherapy (Biologic Therapy) CAGR by Revenue and Volume, 2012-2024
Table Hormonal Therapy CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Blood Cancer CAGR by Revenue and Volume, 2012-2018
Table Breast Cancer CAGR by Revenue and Volume, 2012-2018
Table Gastrointestinal Cancer CAGR by Revenue and Volume, 2012-2018
Table Prostate Cancer CAGR by Revenue and Volume, 2012-2018
Table Respiratory/Lung Cancer CAGR by Revenue and Volume, 2012-2018
Table Other Cancers CAGR by Revenue and Volume, 2012-2018
Table Global Cancer Treatment Drugs Market by Vendors, 2012-2018 (USD Million)
Table Global Cancer Treatment Drugs Market by Vendors, 2012-2018 (in Volume)
Table Global Cancer Treatment Drugs Market Share by Vendors, 2012-2018 (USD Million)
Table Global Cancer Treatment Drugs Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Profile List
Table Microecological Modulator Operating Data of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Profile List
Table Microecological Modulator Operating Data of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Profile List
Table Microecological Modulator Operating Data of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Profile List
Table Microecological Modulator Operating Data of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Profile List
Table Microecological Modulator Operating Data of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Profile List
Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Profile List
Table Microecological Modulator Operating Data of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Profile List
Table Microecological Modulator Operating Data of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen Idec Profile List
Table Microecological Modulator Operating Data of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Profile List
Table Microecological Modulator Operating Data of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Profile List
Table Microecological Modulator Operating Data of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Profile List
Table Microecological Modulator Operating Data of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Profile List
Table Microecological Modulator Operating Data of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ipsen Profile List
Table Microecological Modulator Operating Data of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Profile List
Table Microecological Modulator Operating Data of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Cancer Treatment Drugs Picture
Figure Industry Chain Structure of Cancer Treatment Drugs
Figure SWOT of Cancer Treatment Drugs
Figure Chemotherapy Market Size and Growth, 2012-2018 (USD Million)
Figure Chemotherapy Market Size and Growth, 2012-2018 (in Volume)
Figure Targeted Therapy Market Size and Growth, 2012-2018 (USD Million)
Figure Targeted Therapy Market Size and Growth, 2012-2018 (in Volume)
Figure Immunotherapy (Biologic Therapy) Market Size and Growth, 2012-2018 (USD Million)
Figure Immunotherapy (Biologic Therapy) Market Size and Growth, 2012-2018 (in Volume)
Figure Hormonal Therapy Market Size and Growth, 2012-2018 (USD Million)
Figure Hormonal Therapy Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Figure Chemotherapy Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Chemotherapy Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Targeted Therapy Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Targeted Therapy Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Immunotherapy (Biologic Therapy) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Immunotherapy (Biologic Therapy) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Hormonal Therapy Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Hormonal Therapy Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Others Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Others Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Blood Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Breast Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Gastrointestinal Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Prostate Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Respiratory/Lung Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Other Cancers Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Cancer Treatment Drugs Market Concentration by Region
Figure Marketing Channels Overview


More Publications